Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | RC118 |
Synonyms | |
Therapy Description |
RC118 is an antibody-drug conjugate (ADC) comprising a monoclonal antibody targeting an undisclosed tumor-associated antigen linked to a cytotoxic agent, which potentially induces tumor cell killing (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
RC118 | RC 118|RC-118 | RC118 is an antibody-drug conjugate (ADC) comprising a monoclonal antibody targeting an undisclosed tumor-associated antigen linked to a cytotoxic agent, which potentially induces tumor cell killing (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04914117 | Phase I | RC118 | A Study of RC118 in Patients With Locally Advanced Unresectable/Metastatic Solid Tumours | Completed | AUS | 0 |